AH Capital Management as of June 30, 2025
Portfolio Holdings for AH Capital Management
AH Capital Management holds 10 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 32.3 | $101M | 2.7M | 36.79 | |
| Omada Health (OMDA) | 27.0 | $84M | 4.6M | 18.30 | |
| Block Cl A (XYZ) | 22.1 | $69M | 1.0M | 67.93 | |
| Maze Therapeatics (MAZE) | 6.7 | $21M | 1.7M | 12.27 | |
| Bioage Labs (BIOA) | 4.3 | $13M | 3.2M | 4.13 | |
| Nautilus Biotechnology (NAUT) | 4.1 | $13M | 18M | 0.72 | |
| Erasca (ERAS) | 1.2 | $3.6M | 2.9M | 1.27 | |
| Opendoor Technologies (OPEN) | 1.1 | $3.3M | 6.2M | 0.53 | |
| Camp4 Therapeutics Corp (CAMP) | 1.0 | $3.1M | 2.1M | 1.45 | |
| Ginkgo Bioworks Holdings Cl A New (DNA) | 0.4 | $1.2M | 109k | 11.25 |
